Clinical Study Brings iCAD’s Colon CAD Closer to Market
Colon cancer is among the most preventable cancers when caught early. More than 82 million Americans are eligible for colorectal cancer screening. Currently, diagnostics are […]
news2
[Quick Take] Interview with Dallas Dryden, Director of Sales at PDLabs
PDLabs offers Transdermal Verapamil (TV) 15% Gel, a painless, non-invasive treatment for fibrotic tissue disorders such as Peyronie’s disease. TV 15% has been used to […]
[Quick Take] Interview with Kirt Kirtland, President & CEO of Starion Instruments
Starion Instruments‘ uses focused thermal energy and pressure to simultaneously seal and divide tissue. By applying direct heat instead of electrical, radio frequency or ultrasonic […]
[Quick Take] Interview with Dan Sade Hochstadter, CEO of Keren Medical
Keren Medical is developing anastomosis suturing technology for minimally invasive surgeries (an anastomosis is an operation to connect two body parts). The company’s flagship product […]
[Quick Take] Interview with Edward Leary, President & CEO of ContraVac
In this quick interview from the AUA Meeting, Charlottesville, VA-based ContraVac, discusses SpermCheck Vasectomy. Using only a few drop of semen, the diagnostic can confirm […]
STAAR Surgical Goes Viral
As someone who is celebrating a second anniversary of perfect vision, I tend to be a strong proponent of the laser eye surgery. LASIK gets […]
CryoLife-BioForm Eye Browplasties
BioGlue is now available for use in browlift cosmetic and plastic surgery in the EU. CryoLife, maker of BioGlue, has had its eyes set on […]
Hologic Gets Heptatis C, HPV with Third Wave Acquisition
Hologic, an established provider of diagnostic products and therapeutic devices, will acquire Third Wave Technologies in a $580 million deal. Third Wave develops molecular diagnostic […]
[Video Profile] Interview with Bob Mills, President of Envisioneering Medical
Prostate cancer is the second leading cause of cancer death in men. The cancer stems from a malignant tumor that originates in the prostate gland. […]
Escalon Acquires JAS Diagnostics
On Thursday, Wayne, PA-based Escalon Medical acquired JAS Diagnostics (JAS) through its Drew Scientific division for $1.2 million in cash and $800,000 in notes payable. […]